Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLR-07-23 in Primary Chronic Venous Disease
NCT07684833Phase 3Not yet recruiting
- Start
- Nov 2026
- Primary completion
- May 2027
01
Overview
A Phase 3 trial of heparan sulfate in chronic venous disease (CVD). Planned start Nov 2026; status: not yet recruiting.
02
Drugs
heparan sulfate
03
Conditions
chronic venous disease (CVD)
Beyond the preview
Go deeper on NCT07684833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07684833.